These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 18243718

  • 21. Tumor M2-pyruvate kinase as tumor marker in exocrine pancreatic cancer a meta-analysis.
    Kumar Y, Gurusamy K, Pamecha V, Davidson BR.
    Pancreas; 2007 Aug; 35(2):114-9. PubMed ID: 17632316
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages.
    Jou YJ, Lin CD, Lai CH, Tang CH, Huang SH, Tsai MH, Chen SY, Kao JY, Lin CW.
    Clin Chim Acta; 2011 Jul 15; 412(15-16):1357-65. PubMed ID: 21497587
    [Abstract] [Full Text] [Related]

  • 34. Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls.
    Hardt PD, Toepler M, Ngoumou B, Rupp J, Kloer HU.
    Anticancer Res; 2003 Jul 15; 23(2A):851-3. PubMed ID: 12820312
    [Abstract] [Full Text] [Related]

  • 35. Clinical significance of serum tumour M2-PK and CA19-9 detection in the diagnosis of cholangiocarcinoma.
    Li YG, Zhang N.
    Dig Liver Dis; 2009 Aug 15; 41(8):605-8. PubMed ID: 19168405
    [Abstract] [Full Text] [Related]

  • 36. Determination of pyruvate kinase type tumor M2 in human renal cell carcinoma: a suitable tumor marker?
    Varga Z, Hegele A, Stief T, Heidenreich A, Hofmann R.
    Urol Res; 2002 May 15; 30(2):122-5. PubMed ID: 12086017
    [Abstract] [Full Text] [Related]

  • 37. Pre-analytical problems in the measurement of tumor type pyruvate kinase (tumor M2-PK).
    Oremek GM, Gerstmeier F, Sauer-Eppel H, Sapoutzis N, Wechsel HW.
    Anticancer Res; 2003 May 15; 23(2A):1127-30. PubMed ID: 12820359
    [Abstract] [Full Text] [Related]

  • 38. Fecal pyruvate kinase concentrations (ELISA based on a combination of clone 1 and clone 3 antibodies) for gastric cancer screening.
    Hardt PD, Toepler M, Ngoumou B, Rupp J, Kloer HU.
    Anticancer Res; 2003 May 15; 23(2A):855-7. PubMed ID: 12820313
    [Abstract] [Full Text] [Related]

  • 39. Tumor type M2 pyruvate kinase expression in metastatic renal cell carcinoma.
    Roigas J, Deger S, Schroeder J, Wille A, Turk I, Brux B, Jung K, Schnorr D, Loening SA.
    Urol Res; 2003 Dec 15; 31(6):358-62. PubMed ID: 14513300
    [Abstract] [Full Text] [Related]

  • 40. Tumor M2-pyruvate kinase in lung cancer patients: immunohistochemical detection and disease monitoring.
    Schneider J, Neu K, Grimm H, Velcovsky HG, Weisse G, Eigenbrodt E.
    Anticancer Res; 2002 Dec 15; 22(1A):311-8. PubMed ID: 12017309
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.